Dr. Czarnogorski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
50 Irving St NW
Washington, DC 20422Phone+1 202-745-8000Fax+1 202-745-8284
Education & Training
- George Washington UniversityFellowship, Infectious Disease, 2006 - 2008
- George Washington UniversityResidency, Internal Medicine, 2004 - 2006
- University of California (San Francisco)Internship, Internal Medicine, 2003 - 2004
- Georgetown University School of MedicineClass of 2003
Certifications & Licensure
- DC State Medical License 2004 - 2027
- MD State Medical License 2008 - 2012
- VA State Medical License 2005 - 2008
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Patient Participant Perspectives on Implementation of Long-Acting Cabotegravir and Rilpivirine: Results From the Cabotegravir and Rilpivirine Implementation Study in E...Cassidy A Gutner, Marc van der Valk, Joaquin Portilla, Eliette Jeanmaire, Leïla Belkhir
Journal of the International Association of Providers of AIDS Care. 2024-09-02 - 6 citationsSafety and Effectiveness From the Cabotegravir and Rilpivirine Implementation Study in European Locations Study: Phase 3b Hybrid Type III Implementation Study Integrat...Celia Jonsson-Oldenbüttel, Jade Ghosn, Marc van der Valk, Eric Florence, Francisco Vera
Journal of Acquired Immune Deficiency Syndromes. 2024-08-15 - 2 citationsImplementation of long-acting cabotegravir and rilpivirine: primary results from the perspective of staff study participants in the Cabotegravir And Rilpivirine Implem...Cassidy A Gutner, Laurent Hocqueloux, Celia Jonsson-Oldenbüttel, Linos Vandekerckhove, Berend J van Welzen
Journal of the International AIDS Society. 2024-07-01
Press Mentions
- Long-Acting Injectable HIV Treatment Is Feasible, Even During COVID-19July 20th, 2021
- Virtual Reality Experience Puts Providers in the Shoes of People Living with HIVOctober 14th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: